Related references
Note: Only part of the references are listed.Combinational strategies of metformin and chemotherapy in cancers
Hui-Hui Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Relationship between HbA1c and cancer in people with or without diabetes: a systematic review
C. Hope et al.
DIABETIC MEDICINE (2016)
Serum glucose and hemoglobin A1C levels at cancer diagnosis and disease outcome
Ben Boursi et al.
EUROPEAN JOURNAL OF CANCER (2016)
Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
Xing-kang He et al.
MEDICINE (2016)
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression
Patrizia Ferroni et al.
ONCOLOGIST (2016)
Association between markers of glucose metabolism and risk of colorectal cancer
Jinming Xu et al.
BMJ OPEN (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
Andrea DeCensi et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Global estimates of undiagnosed diabetes in adults
Jessica Beagley et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis
Shinan Yin et al.
DIAGNOSTIC PATHOLOGY (2014)
Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
Zu-Bing Mei et al.
PLOS ONE (2014)
Obesity and colorectal cancer: Role of adipokines in tumor initiation and progression
Silvia Riondino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The Dysfunction of NK Cells in Patients with Type 2 Diabetes and Colon Cancer
Pawel Piatkiewicz et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
Metabolic Dysregulation of the Insulin-Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971-2008)
Niyati Parekh et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis
Ming Yin et al.
ONCOLOGIST (2013)
Glycated hemoglobin A1c is superior to fasting plasma glucose as an independent risk factor for colorectal neoplasia
Yao-Chun Hsu et al.
CANCER CAUSES & CONTROL (2012)
Genetic Variants, Prediagnostic Circulating Levels of Insulin-like Growth Factors, Insulin, and Glucose and the Risk of Colorectal Cancer: The Multiethnic Cohort Study
Nicholas J. Ollberding et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Obesity-Driven Inflammation and Colorectal Cancer
N. Vazzana et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Effect of Elevated Basal Insulin on Cancer Incidence and Mortality in Cancer Incident Patients
Rachel Dankner et al.
DIABETES CARE (2012)
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
R. J. Stevens et al.
DIABETOLOGIA (2012)
Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Is Diabetes Mellitus an Independent Risk Factor for Colon Cancer and Rectal Cancer?
Hiroki Yuhara et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
David R. Whiting et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies
Ying Jiang et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)
Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms
Olga Giouleme et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
Tanja Stocks et al.
PLOS MEDICINE (2009)
Glycosylated Hemoglobin and Risk of Colorectal Cancer in Men and Women, the European Prospective Investigation into Cancer and Nutrition
Sabina Rinaldi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: A case-control study
Ali A. Siddiqui et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: The Japan public health center-based prospective study
Tetsuya Otani et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Prospective study of hyperglycemia and cancer risk
Par Stattin et al.
DIABETES CARE (2007)
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria
K Rapp et al.
DIABETOLOGIA (2006)
Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer
Patrizia Ferroni et al.
ONCOLOGY (2006)
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
SC Larsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
A prospective study of plasma C-peptide and colorectal cancer risk in men
J Ma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
YX Yang et al.
GASTROENTEROLOGY (2004)
Plasma insulin, IGF-binding proteins-1 and-2 and risk of colorectal cancer: A prospective study in northern Sweden
R Palmqvist et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Association between serum carcinoembryonic antigen and endothelial cell adhesion molecules in colorectal cancer
M Roselli et al.
ONCOLOGY (2003)
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women
R Kaaks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
E Bonora et al.
DIABETES CARE (2000)